威雅利(00854.HK)年度虧損擴大282.6%至7255.3萬港元
格隆匯5月28日丨威雅利(00854.HK)公佈,截至2020年3月31日止年度,實現收益31.75億港元,同比減少13.9%;毛利2.06億港元,同比減少37.1%;公司擁有人應占虧損7255.3萬港元,同比擴大282.6%;每股基本虧損85.15港仙。
期內虧損擴大主要是由於回顧年度內的收益及毛利率下跌,令毛利減少所致。毛利率下降主要歸因於需求疲弱引發激烈的價格競爭以及我們清理於上財政年度積累的緩衝庫存所致。此外,人民幣匯價下跌進一步削弱中國國內客户的購買力,集團不得不提供更具競爭力的價格以應對變化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.